- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Human leukocyte antigen DR alpha (HLA-DRA) is a major histocompatibility complex class II protein encoded by the HLA-DRA gene and forms the alpha chain of the HLA-DR antigen receptor responsible for peptide antigen presentation to CD4-positive T lymphocytes. HLA-DRA Antibody for WB enables detection of this MHC class II protein by western blot, allowing analysis of HLA-DR alpha expression in immune cells and experimental systems studying antigen presentation pathways.
HLA-DR is a heterodimeric receptor composed of the HLA-DRA alpha chain paired with a beta chain encoded by HLA-DRB genes. Together these two chains form the HLA-DR antigen complex, a key component of the MHC class II antigen presentation pathway. This receptor binds peptides derived from extracellular proteins processed in endosomal compartments and presents them at the cell surface for recognition by CD4-positive helper T lymphocytes. Through this mechanism, the HLA-DR complex plays a central role in adaptive immune activation and immune surveillance.
HLA-DRA antibody reagents detect the HLA-DR alpha chain, which is frequently described in immunology literature as HLA-DR alpha or the MHC class II DR alpha chain. Expression of HLA-DR is tightly regulated and is typically associated with professional antigen-presenting cells such as B lymphocytes, macrophages, and dendritic cells. However, HLA-DR expression can also be induced in other cell types during immune activation through cytokine signaling pathways, particularly following stimulation by interferon-gamma. Increased expression of HLA-DR molecules is commonly observed in inflammatory conditions, autoimmune disease, infection, and within tumor microenvironments characterized by immune cell infiltration.
Western blot analysis provides a useful method for evaluating HLA-DRA protein expression and confirming presence of the HLA-DR alpha chain in immune cell lysates or experimental models. Detection of HLA-DR alpha by western blot supports studies examining MHC class II expression, antigen presentation pathways, and immune signaling mechanisms. Clone FGI-8 is a recombinant rabbit monoclonal antibody that recognizes HLA-DRA and enables detection of the HLA-DR alpha chain in western blot experiments designed to analyze immune-related protein expression.
Optimal dilution of the HLA-DR antibody should be determined by the researcher.
A synthetic peptide specific to human HLA-DR alpha was used as the immunogen for the HLA-DR antibody.
Store the HLA-DR antibody at -20oC.
HLA-DR alpha antibody, HLA-DR antibody, HLA-DR antigen antibody, MHC class II DR antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.